Overview Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy Status: Recruiting Trial end date: 2027-08-19 Target enrollment: Participant gender: Summary Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients with Duchenne Muscular Dystrophy Phase: Phase 1 Details Lead Sponsor: ENCell